EUVIMEDEUVIMED entdecken
Crossref

A Dual‐Locked and H 2 S‐NO Tandem‐Activatable NIR‐II Nanoagent for Colon Cancer Theranostics

Xinyi Zhang, Ling Li, Yuxin Ren, Xinyi Ma, Hao Zhao iD, Yanli Tang iD

Advanced Materials · 09.11.2026

DOI: 10.1002/adma.75668 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 09.11.2026. Verfasst von Xinyi Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education, Key Laboratory of Analytical Chemistry For Life Science of Shaanxi Pr…. Die Arbeit nennt 79 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Young Scholar Project of Alliance of Advanced Optical Microscopy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dual‐locked activatable theranostics have been emerging as a promising cancer therapy platform. However, most of the reported dual‐locked systems only restricted to enzyme‐responsive probes, new molecular tools with other biomarker‐responsiveness still remain challenging. Moreover, optical manipulation in the second near‐infrared (NIR‐II) window can potentially boost the theranostic efficacy, but having rarely been explored. In this study, we report a dual‐locked and gas tandem‐activatable NIR‐II nanoagent for colon cancer theranostics. Water‐dispersible nanoparticles containing a nitrated organic small molecule (CTBN) and an acid‐responsive NO donor (NONOate; CTBNN‐NPs) are fabricated, displaying negligible emission in visible‐NIR region. Upon uptake by colon cancer cells, CTBNN‐NPs can be tandemly activated by the overexpressed H 2 S and the in situ released NO, thus turning on NIR‐II emission extending to 1200 nm. Moreover, the activated CTBNN‐NPs also demonstrate augmented NIR absorption as well as robust photothermal and type‐I photodynamic performance, achieving NIR‐II fluorescence imaging‐guided efficient photo‐elimination of colon cancer together with NO gas therapy, while exhibiting limited efficacy in the tested cervical and breast cancer models. This work provides a new molecular design approach to dual‐locked and H 2 S‐NO tandem‐activatable nanoagents with gas‐responsive and NIR‐II active capabilities, highlighting the exciting potential for cancer theranostics.

Schlagwörter

Stichwörter der Autor:innen

NIR‐II imagingcolon cancergas therapyphototherapytandem‐activation

Autor:innen und Institutionen

  • Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education, Key Laboratory of Analytical Chemistry For Life Science of Shaanxi Province, School of Chemistry and Chemical Engineering, Shaanxi Normal U…
  • Beijing National Laboratory for Molecular Sciences, Interdisciplinary Research Center For Chemical, Life and Health Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing, P. R. China.

ORCID-Profile: Hao Zhao, Yanli Tang

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Young Scholar Project of Alliance of Advanced Optical Microscopy
  • Chinese Academy of Sciences

Zitieren

APA

Zhang, X., Li, L., Ren, Y., Ma, X., Zhao, H., & Tang, Y. (2026). A Dual‐Locked and H 2 S‐NO Tandem‐Activatable NIR‐II Nanoagent for Colon Cancer Theranostics. Advanced Materials. https://doi.org/10.1002/adma.75668

Vancouver

Zhang X, Li L, Ren Y, Ma X, Zhao H, Tang Y. A Dual‐Locked and H 2 S‐NO Tandem‐Activatable NIR‐II Nanoagent for Colon Cancer Theranostics. Advanced Materials. 2026. doi:10.1002/adma.75668

BibTeX
@article{Zhang2026,
  author = {Zhang, Xinyi and Li, Ling and Ren, Yuxin and Ma, Xinyi and Zhao, Hao and Tang, Yanli},
  title = {A Dual‐Locked and H 2 S‐NO Tandem‐Activatable NIR‐II Nanoagent for Colon Cancer Theranostics},
  journal = {Advanced Materials},
  year = {2026},
  doi = {10.1002/adma.75668}
}
Kostenlos starten →